Fibroblast activation protein: purification, epitope mapping and induction by growth factors.
The human fibroblast activation protein (FAP) defined by monoclonal antibody (MAb) F19 is a cell surface antigen expressed in reactive stromal fibroblasts of breast, colorectal, lung and other epithelial cancers. In contrast to its stroma-specific localization in epithelial neoplasms, FAP is expressed in the malignant mesenchymal cells of bone and soft tissue sarcomas. FAP is transiently expressed in some fetal mesenchymal tissues but is absent or expressed at low levels in most adult tissues. FAP is induced in cultured fibroblasts and, in these cells, consists of a M(r) 95,000 subunit (FAP alpha) carrying the F19 epitope and a non-covalently bound M(r) 105,000 subunit (FAP beta) lacking the F19 epitope. Using MAb F19 and 5 newly derived MAbs, we identify 3 distinct epitopes on FAP alpha and tentatively assign one epitope to FAP beta. Analysis of detergent extracts of a FAP alpha high beta- sarcoma cell line by size exclusion-high performance liquid chromatography (HPLC) revealed that FAP alpha does not elute as a M(r) 95,000 species but as part of a high-molecular weight complex (M(r) > 400,000) that dissociates into M(r) 95,000 subunits in SDS gels. Immunoaffinity purification of FAP alpha followed by tryptic digestion, reversed-phase HPLC and microsequencing identified 3 unique FAP alpha peptides, with 2 showing sequence similarity (23/38 identical amino acids) to segments of CD26, a T-cell activation antigen. CD26 is a membrane-bound enzyme (dipeptidyl aminopeptidase IV), but immunopurified FAP alpha has little if any dipeptidase activity with typical CD26 substrates. Finally, studies with FAPlow leptomeningeal fibroblasts revealed that transforming growth factor-beta, 12-O-tetradecanoyl phorbol-13-acetate and retinoids can upregulate FAP expression, whereas serum and several other factors had no or little effect on FAP levels. FAP and CD26 may belong to a family of structurally related but functionally distinct activation proteins that are expressed on different cell types and show unique modes of regulation in normal and malignant cells.
Rettig
W J
WJ
Program of Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Su
S L
SL
Fortunato
S R
SR
Scanlan
M J
MJ
Raj
B K
BK
Garin-Chesa
P
P
Healey
J H
JH
Old
L J
LJ
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis; D000918:Antibody Specificity; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002478:Cells, Cultured; D002846:Chromatography, Affinity; D002851:Chromatography, High Pressure Liquid; D003001:Cloning, Molecular; D018819:Dipeptidyl Peptidase 4; D010450:Endopeptidases; D000939:Epitopes / Q000032:analysis*; D018093:Gelatinases; D006133:Growth Substances / Q000096:biosynthesis* / Q000276:immunology / Q000302:isolation & purification* / Q000494:pharmacology*; D006801:Humans; D007114:Immunization; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D046911:Macromolecular Substances; D008565:Membrane Proteins; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D008970:Molecular Weight; D010316:Particle Size; D012697:Serine Endopeptidases; D014212:Tretinoin / Q000494:pharmacology; D000099167:Fibroblast Activation Protein Alpha
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D018819:Dipeptidyl Peptidase 4; D010450:Endopeptidases; D000939:Epitopes; D018093:Gelatinases; D006133:Growth Substances; D046911:Macromolecular Substances; D008565:Membrane Proteins; D012697:Serine Endopeptidases; D014212:Tretinoin; D000099167:Fibroblast Activation Protein Alpha